This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
zacks-consensus-estimate: Archive
Lovesac (LOVE) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Lovesac (LOVE) delivered earnings and revenue surprises of +37.50% and -0.20%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
LOVENegative Net Change AZOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
KalVista Pharmaceuticals, Inc. (KALV) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
KalVista Pharmaceuticals (KALV) delivered earnings and revenue surprises of -23.08% and -20.91%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
KALVPositive Net Change NRIXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Hooker Furniture (HOFT) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Hooker Furniture (HOFT) delivered earnings and revenue surprises of -158.33% and -9.89%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
HOFTPositive Net Change BSETPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Culp, Inc. (CULP) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Culp (CULP) delivered earnings and revenue surprises of +83.33% and -11.84%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
CULPPositive Net Change LGCYNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Lesaka Technologies (LSAK) Q4 Earnings Beat Estimates
by Zacks Equity Research
Lesaka Technologies (LSAK) delivered earnings and revenue surprises of +25.00% and -37.41%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LSAKNegative Net Change BYRNPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Oxford Industries (OXM) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Oxford Industries (OXM) delivered earnings and revenue surprises of +4.13% and -1.11%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
OXMPositive Net Change MTNPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Vince Holding Corp. (VNCE) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Vince Holding (VNCE) delivered earnings and revenue surprises of +575.00% and +0.50%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
VNCENegative Net Change LUXENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Aviat Networks, Inc. (AVNW) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Aviat Networks (AVNW) delivered earnings and revenue surprises of +93.02% and +1.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AVNWPositive Net Change PAYXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Will Ciena (CIEN) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Ciena (CIEN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
CIENPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for DocuSign (DOCU): Time to Buy?
by Zacks Equity Research
DocuSign (DOCU) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
DOCUPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Can Magic Software (MGIC) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Magic Software (MGIC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
MGICPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Rising for Jefferies (JEF): Will It Gain?
by Zacks Equity Research
Jefferies (JEF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
JEFPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Adtalem (ATGE) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Adtalem (ATGE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ATGEPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
CION Investment Corporation (CION) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
CION Investment Corporation (CION) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
CIONNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Agree Realty (ADC) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Agree Realty (ADC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ADCPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Crown Castle (CCI) Rating Upgrade to Buy
by Zacks Equity Research
Crown Castle (CCI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CCIPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About SGS (SGSOY) Rating Upgrade to Buy
by Zacks Equity Research
SGS (SGSOY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
SGSOYPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes NatWest (NWG) a New Buy Stock
by Zacks Equity Research
NatWest (NWG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NWGPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
DocuSign (DOCU) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
DocuSign (DOCU) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
DOCUPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About PepsiCo (PEP) Rating Upgrade to Buy
by Zacks Equity Research
PepsiCo (PEP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
PEPPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
First Hawaiian (FHB) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
First Hawaiian (FHB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
FHBPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
NextEra (NEE) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
NextEra (NEE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NEEPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Venture Global (VG) Up 9.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Venture Global (VG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
VGPositive Net Change CHRDPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is Westport (WPRT) Down 30.5% Since Last Earnings Report?
by Zacks Equity Research
Westport (WPRT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
WPRTNegative Net Change AXLPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is Xenon Pharmaceuticals (XENE) Up 4.2% Since Last Earnings Report?
by Zacks Equity Research
Xenon Pharmaceuticals (XENE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
XENEPositive Net Change NTLANegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate